Background. Ascorbic acid (AA) supplementation has been suggested to afford erythropoietin hyporesponsiveness and high levels of ferritin in haemodialysis (HD) patients. However, little is known about the possible side effects of this policy on vascular calcification (VC). VC, induced by a high-phosphate and uraemic milieu, is characterized by a passive deposition of calcium-phosphate (Ca-P) and an active transformation of vascular smooth muscle cells (VSMCs) in osteoblastic-like cells. The aim of these studies was to characterize the combined effects of AA and P on VC.Materials and methods. Rat VSMCs were challenged with inorganic P (Pi) and AA, and Ca deposition analysis was performed to quantify VC. To investigate VSMC osteoblastic differentiation, we analysed α-actin protein content and core-binding factor alpha-1 (Cbfα1/RUNX2) messenger RNA (mRNA) expression.Results. When incubated with 5 mM Pi, VSMCs showed a significant increase in Ca deposition compared to control cells. Interestingly, the addition of AA in the calcification medium resulted in a dose-dependent increase in Pi-induced Ca deposition. At the same time, the combined effect of AA and Pi on VSMCs resulted in the reduction of α-actin protein content and in a 4-fold increase of Cbfα1/RUNX2 mRNA expression.Conclusions. We demonstrated that AA combined with Pi increases Ca deposition in rat VSMCs. The role of AA as cofactor in osteoblastic differentiation was demonstrated by phenotypic changes in VSMCs and enhanced bone mineralization key gene expression. These in vitro preliminary data suggest a potential role for AA combined with Pi in worsening VC.
Combined effects of ascorbic acid and phosphate on rat VSMC osteoblastic differentiation / P. Ciceri, E. Volpi, I. Brenna, L. Arnaboldi, L. Neri, D. Brancaccio, M. Cozzolino. - In: NEPHROLOGY DIALYSIS TRANSPLANTATION. - ISSN 0931-0509. - 27:1(2012 Jan), pp. 122-127.
|Titolo:||Combined effects of ascorbic acid and phosphate on rat VSMC osteoblastic differentiation|
|Parole Chiave:||ascorbic acid; phosphate; vascular calcification; vascular smooth muscle cell|
|Settore Scientifico Disciplinare:||Settore MED/14 - Nefrologia|
Settore MED/44 - Medicina del Lavoro
|Data di pubblicazione:||gen-2012|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1093/ndt/gfr284|
|Appare nelle tipologie:||01 - Articolo su periodico|